Yale University Wins $4 Million Trade Secret Misappropriation Case
In a notable decision, a Delaware federal jury has awarded $4 million in a case involving Yale University and Biohaven Therapeutics against RA Capital Management GP and Avilar Therapeutics. The jury found that the defendants breached a confidentiality agreement and misappropriated a Yale-developed trade secret related to the design of protein-degrading drug molecules. This ruling…